Introduction Liver transplantation (LT) for hepatocellular carcinoma (HCC) is a satisfactory therapeutic choice in patients with “early HCC” selected according to Milan criteria. However, the risk of HCC recurrence after LT is about 7-20% at five years and molecular markers which can predict recurrence are still lacking. We investigated in HCC samples and LC surrounding tissues the significance of VEGFR-2, HSP90, and GRP78/BiP expression in patients with HCC who underwent LT in a western transplantation center and their possible role as molecular markers of recurrence. Methods 42 patients (35 M, 7 F) with early HCC who underwent LT between 2012 and 2013 were enrolled. The tumor recurrence rate was analyzed after a minimum follow-up of...
Milan and University of California at San Francisco (UCSF) criteria are used to select patients with...
BackgroundSerum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurr...
Objective Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver...
Introduction Liver transplantation (LT) for hepatocellular carcinoma (HCC) is a satisfactory thera...
Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplan...
Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplan...
Background Though the precise criteria for accessing LT are consistently being applied, HCC recurren...
OBJECTIVE:Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
Subject headings carcinoma, hepatocellular; neoplasm metasta sis; angiogenesis; liver neoplasms AIM ...
Background and Aims. Patients with hepatocellular carcinoma (HCC) who undergo orthotopic liver trans...
Background: Though the precise criteria for accessing LT are consistently being applied, HCC recurre...
Milan and University of California at San Francisco (UCSF) criteria are used to select patients with...
BackgroundSerum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurr...
Objective Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver...
Introduction Liver transplantation (LT) for hepatocellular carcinoma (HCC) is a satisfactory thera...
Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplan...
Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplan...
Background Though the precise criteria for accessing LT are consistently being applied, HCC recurren...
OBJECTIVE:Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
BackgroundThough the precise criteria for accessing LT are consistently being applied, HCC recurrenc...
Subject headings carcinoma, hepatocellular; neoplasm metasta sis; angiogenesis; liver neoplasms AIM ...
Background and Aims. Patients with hepatocellular carcinoma (HCC) who undergo orthotopic liver trans...
Background: Though the precise criteria for accessing LT are consistently being applied, HCC recurre...
Milan and University of California at San Francisco (UCSF) criteria are used to select patients with...
BackgroundSerum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurr...
Objective Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver...